Document is current
Any future updates will be listed below
-
Authors
Frenel, Jean-Sébastien
Mathiot, Laurent https://orcid.org/0000-0001-8601-1226
Cropet, Claire
Borcoman, Edith
Hervieu, Alice
Coquan, Elodie
De La Motte Rouge, Thibault
Saada-Bouzid, Esma
Sabatier, Renaud
Lavaud, Pernelle
Jimenez, Marta
Legrand, François
Le Saux, Olivia
Charafe, Emmanuelle
Gonçalves, Anthony
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03518606 at ClinicalTrials.govDocuments that mention this clinical trial
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study
https://doi.org/10.1136/jitc-2024-010708
-
Funding
Funding for this research was provided by:
Ligue Contre le Cancer (N/A)
Institut National Du Cancer (N/A)
AstraZeneca France (N/A)
Fondation Pierre Fabre (N/A)
- License Information
